Leonhardt Startup CancerCell Expands IP Estate for Bioelectric Treatment of Cancer Tumors
First bioelectric cancer tumor therapy designed for early detection, personalized real time reading, customized communication jamming, stopping cell division, starving blood supply, changing surface protein expression to trigger immunotherapy, customized real time...
LEONHARDT VENTURES TO ENTER INTO WORLDWIDE STRATEGIC COLLABORATION WITH NEURO CODE TECH HOLDINGS FOR CUSTOMIZED BIOELECTRIC CANCER TREATMENTS
Salt Lake City, Utah and Albuquerque, New Mexico, January 23rd, 2017/PRBuzz: BREAKTHROUGH PATENTED AND PATENT PENDING EARLY STAGE TECHNOLOGIES ARE DESIGNED TO DETECT EARLY TUMORS VIA FAINT BIOELECTRIC SIGNALS AND READ HOW A TUMOR IS COMMUNICATING WITH ITSELF AND...